Pages that link to "Q39707323"
Jump to navigation
Jump to search
The following pages link to Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia (Q39707323):
Displaying 50 items.
- Empirical antibiotics targeting Gram-positive bacteria for the treatment of febrile neutropenic patients with cancer (Q24201136) (← links)
- Additional anti-Gram-positive antibiotic treatment for febrile neutropenic cancer patients (Q24246468) (← links)
- Carbapenems in clinical practice: a guide to their use in serious infection (Q28142638) (← links)
- Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity (Q28326763) (← links)
- Chrononephrotoxicity in rat of a vancomycin and gentamicin combination (Q28327696) (← links)
- Curtailing unnecessary vancomycin usage in a hospital with high rates of methicillin resistant Staphylococcus aureus infections (Q28362561) (← links)
- Interventional antimicrobial therapy in febrile neutropenic patients (Q33685834) (← links)
- Virulence of Pseudomonas aeruginosa in a murine model of gastrointestinal colonization and dissemination in neutropenia (Q33769463) (← links)
- Viridans-group streptococcal infections in immunocompromised hosts (Q33865093) (← links)
- Transferable vancomycin and teicoplanin resistance in Enterococcus faecium (Q34042099) (← links)
- Infectious complications of febrile leukopenia (Q34305085) (← links)
- Retrospective review of febrile neutropenia in the Royal Darwin Hospital, 1994-99. (Q34390054) (← links)
- Empirical oral antibiotic therapy for low risk febrile cancer patients with neutropenia (Q34651556) (← links)
- Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Tre (Q34722117) (← links)
- Population pharmacokinetic study of teicoplanin in severely neutropenic patients (Q35124463) (← links)
- Open randomized study of cefepime versus piperacillin-gentamicin for treatment of febrile neutropenic cancer patients (Q35137580) (← links)
- Resistance of enterococci to glycopeptides (Q35284014) (← links)
- Randomized prospective study comparing vancomycin with teicoplanin in the treatment of infections associated with Hickman catheters (Q35341106) (← links)
- Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients (Q35565163) (← links)
- Reduction in clinical response to empiric antimicrobial therapy of febrile granulocytopenic patients receiving TMP/SMX infection prophylaxis (Q35816748) (← links)
- Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit (Q35821697) (← links)
- Vancomycin is not an essential component of the initial empiric treatment regimen for febrile neutropenic patients receiving ceftazidime: a randomized prospective study (Q35836302) (← links)
- Imipenem versus gentamicin combined with either cefuroxime or cephalothin as initial therapy for febrile neutropenic patients (Q35845922) (← links)
- Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients (Q35938407) (← links)
- Effects of inappropriate empirical antibiotic therapy on mortality in patients with healthcare-associated methicillin-resistant Staphylococcus aureus bacteremia: a propensity-matched analysis (Q36078305) (← links)
- Update on management of infections in cancer and stem cell transplant patients (Q36419298) (← links)
- Bowel microorganisms—a target for selective antimicrobial control (Q36536108) (← links)
- Ceftazidime as monotherapy or combined with teicoplanin for initial empiric treatment of presumed bacteremia in febrile granulocytopenic patients (Q36753331) (← links)
- Comparison of two antibiotic regimens (piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancer (Q36758412) (← links)
- Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection (Q37189279) (← links)
- Infections in the compromised child (Q37363595) (← links)
- The child with cancer and infection. I. Empiric therapy for fever and neutropenia, and preventive strategies (Q37469283) (← links)
- Optimal management of acute toxicities of therapy (Q37671247) (← links)
- Role of glycopeptide antibiotics in the treatment of febrile neutropenic patients (Q37864914) (← links)
- Neutropenic fever and sepsis: evaluation and management (Q38202573) (← links)
- Third-generation cephalosporins. A plea to save them for specific infections (Q38611738) (← links)
- Empiric treatment of infection during granulocytopenia: a comprehensive approach (Q38625966) (← links)
- Observations on spiraling empiricism: its causes, allure, and perils, with particular reference to antibiotic therapy (Q38670901) (← links)
- Empirical antibiotics targeting gram-positive bacteria for the treatment of febrile neutropenic patients with cancer. (Q38747206) (← links)
- Controversies in the management of febrile neutropenic cancer patients (Q39603225) (← links)
- Clinical characteristics and antibiotic susceptibility of viridans streptococcal bacteremia in children with febrile neutropenia. (Q40248953) (← links)
- Continental-scale pollution of estuaries with antibiotic resistance genes (Q40439051) (← links)
- Role of glycopeptides as part of initial empirical treatment of febrile neutropenic patients: a meta-analysis of randomised controlled trials (Q40505256) (← links)
- Empiric therapy for infections in the febrile, neutropenic, compromised host (Q40526842) (← links)
- Withholding initial vancomycin in febrile neutropenia despite implanted catheters (Q40533966) (← links)
- Common emergencies in cancer medicine: infectious and treatment-related syndromes, Part I. (Q40561085) (← links)
- Empirical therapy for bacterial infections in neutropenic patients (Q40594924) (← links)
- Cost analysis of 2 empiric antibacterial regimens containing glycopeptides for the treatment of febrile neutropenia in patients with acute leukaemia (Q40638198) (← links)
- Trends in bacterial infections in febrile neutropenic patients: 1986-1992. (Q40643466) (← links)
- Antibiotic treatment of febrile episodes in neutropenic cancer patients. Clinical and economic considerations (Q40651926) (← links)